Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/173271
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling

AutorMartinez-Romero, Jorge; Bueno-Fortes, Santiago CSIC ORCID; Martín-Merino, Manuel; Ramírez de Molina, Ana CSIC ORCID; De Las Rivas, Javier CSIC ORCID CVN
Palabras claveCancer
Colorectal cancer
Colon
Survival
Kaplan-Meier analysis
Gene marker
Bioinformatics
Transcriptomics
Gene expression
Fecha de publicación11-dic-2018
EditorBioMed Central
CitaciónBMC Genomics 19(8): 857 (2018)
Resumen[Background] Identification of biomarkers associated with the prognosis of different cancer subtypes is critical to achieve better therapeutic assistance. In colorectal cancer (CRC) the discovery of stable and consistent survival markers remains a challenge due to the high heterogeneity of this class of tumors. In this work, we identified a new set of gene markers for CRC associated to prognosis and risk using a large unified cohort of patients with transcriptomic profiles and survival information.
[Results] We built an integrated dataset with 1273 human colorectal samples, which provides a homogeneous robust framework to analyse genome-wide expression and survival data. Using this dataset we identified two sets of genes that are candidate prognostic markers for CRC in stages III and IV, showing either up-regulation correlated with poor prognosis or up-regulation correlated with good prognosis. The top 10 up-regulated genes found as survival markers of poor prognosis (i.e. low survival) were: DCBLD2, PTPN14, LAMP5, TM4SF1, NPR3, LEMD1, LCA5, CSGALNACT2, SLC2A3 and GADD45B. The stability and robustness of the gene survival markers was assessed by cross-validation, and the best-ranked genes were also validated with two external independent cohorts: one of microarrays with 482 samples; another of RNA-seq with 269 samples. Up-regulation of the top genes was also proved in a comparison with normal colorectal tissue samples. Finally, the set of top 100 genes that showed overexpression correlated with low survival was used to build a CRC risk predictor applying a multivariate Cox proportional hazards regression analysis. This risk predictor yielded an optimal separation of the individual patients of the cohort according to their survival, with a p-value of 8.25e-14 and Hazard Ratio 2.14 (95% CI: 1.75–2.61).
[Conclusions] The results presented in this work provide a solid rationale for the prognostic utility of a new set of genes in CRC, demonstrating their potential to predict colorectal tumor progression and evolution towards poor survival stages. Our study does not provide a fixed gene signature for prognosis and risk prediction, but instead proposes a robust set of genes ranked according to their predictive power that can be selected for additional tests with other CRC clinical cohorts.
Versión del editorhttps://doi.org/10.1186/s12864-018-5193-9
URIhttp://hdl.handle.net/10261/173271
DOI10.1186/s12864-018-5193-9
ISSN1471-2164
Aparece en las colecciones: (CIC) Artículos
(IBMCC) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
survival_profiling_2018.pdf2,54 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

32
checked on 11-abr-2024

SCOPUSTM   
Citations

45
checked on 20-abr-2024

WEB OF SCIENCETM
Citations

44
checked on 29-feb-2024

Page view(s)

415
checked on 24-abr-2024

Download(s)

345
checked on 24-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons